Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (52 ops.)
Latest filing published 06 Oct 2026 for CYTOKINETICS INC, €24k. Read the official filing
Filing timeline
BuySaleFady Ibraham Malik
Insider track record
Disclosed buys
0
Disclosed sells
52
Signal history
Fady Ibraham Malik: trading record in brief
Fady Ibraham Malik, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Cytokinetics Inc and Rocket Pharmaceuticals, Inc. Over a trading history stretching from 13 May 2021 to 6 October 2026, the count stands at 132 filings.
Sales make up the whole of the open-market record (52 sales, €8.8M). The amount is not disclosed for 2 filings. Other entries cover 17 share grants and 60 option exercises. So far in 2026, the count stands at no purchases and 13 sales.
Most recently, on 6 October 2026, the filings show an option exercise worth €24k in Cytokinetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Fady Ibraham Malik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations132 total
3,500 shares@ US$7.80Common StockSEC:0001061983-26-000098:0
3,500 shares@ US$61.38Common StockSEC:0001061983-26-000098:1
3,500 shares@ US$7.800.0003% mcap0.2% of flowCommon StockSEC:0001061983-26-000096:0
3,500 shares@ US$68.290.0026% mcap1.7% of flowCommon StockSEC:0001061983-26-000096:1
3,500 shares@ US$7.800.0003% mcap0.2% of flowCommon StockSEC:0001061983-26-000092:0
3,500 shares@ US$75.460.0029% mcap1.9% of flowCommon StockSEC:0001061983-26-000092:1
3,500 shares@ US$7.800.0003% mcap1.5% of flowCommon StockSEC:0001061983-26-000088:0
3,500 shares@ US$75.820.0029% mcap14.3% of flowCommon StockSEC:0001061983-26-000088:1
3,500 shares@ US$7.800.0003% mcap1.5% of flowCommon StockSEC:0001061983-26-000084:0
3,500 shares@ US$80.590.0031% mcap15.4% of flowCommon StockSEC:0001061983-26-000084:1
3,500 shares@ US$86.620.0033% mcap16.6% of flowCommon StockSEC:0001061983-26-000075:1
3,500 shares@ US$7.800.0003% mcap1.5% of flowCommon StockSEC:0001061983-26-000075:0
22,862 shares0Common StockSEC:0001140361-26-027678:0
3,500 sharesCommon StockSEC:0001061983-26-000069:0
3,500 sharesCommon StockSEC:0001061983-26-000069:1
3,500 sharesCommon StockSEC:0001061983-26-000067:0
3,500 sharesCommon StockSEC:0001061983-26-000067:1
3,500 shares@ US$7.800.0003% mcap0.2% of flowCommon StockSEC:0001061983-26-000043:0
3,500 shares@ US$65.690.0025% mcap1.6% of flowCommon StockSEC:0001061983-26-000043:1
3,500 shares@ US$7.801.5% of flowCommon StockSEC:0001061983-26-000034:0
1,000 shares@ US$10.600.6% of flowCommon StockSEC:0001061983-26-000034:2
3,500 shares@ US$65.2112.2% of flowCommon StockSEC:0001061983-26-000034:1
1,000 shares@ US$64.753.5% of flowCommon StockSEC:0001061983-26-000034:3
7,636 shares@ US$62.1525.8% of flowCommon StockSEC:0001061983-26-000027:0
27,306 shares0Common StockSEC:0001061983-26-000020:0
25 of 132 declarations
